ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

December 11, 1992

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

IOM Report: Nationwide Crisis Facing Cancer Care

September 13, 2013

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005